EP 1077995 A1 20010228 - ANTIANGIOGENIC DRUG TO TREAT CANCER, ARTHRITIS AND RETINOPATHY
Title (en)
ANTIANGIOGENIC DRUG TO TREAT CANCER, ARTHRITIS AND RETINOPATHY
Title (de)
ANTIANGIOGENETISCH WIRKENDE SUBSTANZ ZUR BEHANDLUNG VON KREBS, ARTHRITIS UND RETINOPATHIE
Title (fr)
MEDICAMENT ANTI-ANGIOGENIQUE POUR LE TRAITEMENT DU CANCER, DE L'ARTHRITE ET DE LA RETINOPATHIE
Publication
Application
Priority
- US 9911308 W 19990521
- US 8355098 A 19980522
Abstract (en)
[origin: WO9961466A1] Compounds having Formula (I), or pharmaceutically acceptable salts or prodrugs thereof, are useful for treating pathological states which arise from or are exacerbated by angiogenesis. The invention also relates to pharmaceutical compositions comprising these compounds and to methods of inhibiting angiogenesis in a mammal.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61P 19/02 (2006.01); A61P 27/02 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07K 5/065 (2006.01); C07K 5/11 (2006.01)
CPC (source: EP)
A61P 19/02 (2017.12); A61P 27/02 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12); C07K 5/06078 (2013.01); C07K 5/1019 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
See references of WO 9961466A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9961466 A1 19991202; CA 2332772 A1 19991202; EP 1077995 A1 20010228; JP 2002516337 A 20020604
DOCDB simple family (application)
US 9911308 W 19990521; CA 2332772 A 19990521; EP 99925742 A 19990521; JP 2000550870 A 19990521